As cited by the research report titled ‘Europe Test Strips Market Size By End-use, By Product, Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027’, available with Market Study Report, Europe test strips market is anticipated to amass a value of USD 2.5 billion by the end of the forecast period 2021-2027.
 

Increased risk and prevalence of diseases like diabetes owing to changing lifestyles is catalyzing Europe test strips market growth. In particular, medical conditions like hypoglycemia and hyperglycemia, which have high morbidity and mortality rates are increasing in the region, are reinforcing the diabetes test strips demand.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3736378/
 

Additionally, ongoing technological advancements in line with development of smarter test trips is positively swaying the market dynamics. Furthermore, increasing geriatric population in Europe is at a higher risk of acquired such blood sugar related diseases, in turn, is generating lucrative prospects for the businesses in this market
 

For the record, the World Health Organization (WHO) claims that 6 out of 10 people above 15 years of age do not engage in any physical activities like sports or exercise. These individuals are at a higher risk of acquiring diabetes. In addition, WHO also cites that over 60 million people in Europe have diabetes, of which, 9.6% are women and 10.3% are men, indicating a heightened demand for test strips in the region.
 

Based on product type, Europe test strips industry is segmented into diabetes test strips and urine test strips. As cited in the report, the urine test strips segment generated revenues worth USD 96 million in the recent past, attributable to a worrisome rise in the number of kidney ailments and urinary tract infections (UTIs). Due to the fear of such diseases the young people are buying test strips to get themselves tested, further contributing towards increase in the sales of test strip in Europe.
 

Speaking of the end user spectrum, the marketplace is divided into home care, hospitals, diagnostic laboratories and others. As per the report, presence of well-established healthcare infrastructure with skilled professionals is augmenting the industry outlook across the end-users.
 

Elaborating on the competitive landscape, Taidoc Technology Corporation, Siemens Healthineers AG, Roche Diabetes Care GmbH, Lifescan Inc., Henry Schein Inc., B. Braun Melsungen AG., Arkray Inc., Ascensia Diabetes Care, Acon Laboratories Inc., and Abbott Laboratories are the top-tier players influencing the Europe test strips industry dynamics.